Covid-19 – Page 7 – artdiamondblog.com

Chinese Citizens Tune Out Randomly Linked Nonsense Propaganda Phrases

(p. B1) China is now one of the last places on earth trying to eliminate Covid-19, and the Communist Party has relied heavily on propaganda to justify increasingly long lockdowns and burdensome testing requirements that can sometimes lead to three tests a week.

The barrage of messages — online and on television, loudspeakers and social platforms — has become so overbearing that some citizens say it has drowned out their frustrations, downplayed the reality of the country’s tough coronavirus rules and, occasionally, bordered on the absurd.

. . .

(p. B4) Yang Xiao, a 33-year-old cinematographer in Shanghai who was confined to his apartment for two months during a lockdown this year, had grown tired of them all.

“With the Covid control, propaganda and state power expanded and occupied all aspects of our life,” he said in a phone interview. Day after day, Mr. Yang heard loudspeakers in his neighborhood repeatedly broadcasting a notice for P.C.R. testing. He said the announcements had disturbed his sleep at night and woke him up at dawn.

“Our life was dictated and disciplined by propaganda and state power,” he said.

To communicate his frustrations, Mr. Yang selected 600 common Chinese propaganda phrases, such as “core awareness,” “obey the overall situation” and “the supremacy of nationhood.” He gave each phrase a number and then put the numbers into Google’s Random Generator, a program that scrambles data.

He ended up with senseless phrases such as “detect citizens’ life and death line,” “strictly implement functions” and “specialize overall plans without slack.” Then he used a voice program to read the phrases aloud and played the audio on a loudspeaker in his neighborhood.

No one seemed to notice the five minutes of computer-generated nonsense.

When Mr. Yang uploaded a video of the scene online, however, more than 1.3 million people viewed it. Many praised the way he used government language as satire. Chinese propaganda was “too absurd to be criticized using logic,” Mr. Yang said. “I simulated the discourse like a mirror, reflecting its own absurdity.”

His video was taken down by censors.

. . .

In June [2022], dozens of residents protested against the police and Covid control workers who installed chain-link fences around neighborhood apartments. When a protester was shoved into a police car and taken away, one man shouted: “Freedom! Equality! Justice! Rule of law!” Those words would be familiar to most Chinese citizens: They are commonly cited by state media as core socialist values under Mr. Xi.

For the full story, see:

Zixu Wang. “China’s Covid Propaganda, Often Seen as Absurd, Stirs Rebellion.” The New York Times (Friday, September 30, 2022): B1 & B4.

[Note: ellipses, and bracketed year, added.]

(Note: the online version of the story has the date Sept. 29, 2022, and has the title “China’s ‘Absurd’ Covid Propaganda Stirs Rebellion.”)

With Both Covid and Monkeypox, C.D.C. Wrongly “Tried to Maintain Control Over Testing”

(p. A14) Too often in a crisis, government officials look for easy solutions, with dramatic and immediate impact. But there are none for managing pandemics.

“A pandemic is by definition a problem from hell. You’re vanishingly unlikely to be able to remove all of its negative consequences,” said Bill Hanage, an epidemiologist at the Harvard T.H. Chan School of Public Health.

Instead, he added, officials should bet on combinations of imperfect strategies, with an emphasis on speed over accuracy.

In both the coronavirus pandemic and the monkeypox outbreak, for example, the C.D.C. at first tried to maintain control over testing, instead of disseminating the responsibility as widely as possible. The move led to limited testing, and left health officials blind to the spread of the viruses.

The Food and Drug Administration was slow to help academic labs develop alternatives for testing, and encouraged the highest quality of diagnosis. It may be reasonable for officials to ask which test is faster or which one produces the least errors, Dr. Hanage said, but “all of them are better than not doing anything.”

For the full commentary, see:

Apoorva Mandavilli. “Unprepared for Covid and Monkeypox. And the Next Outbreak, Too.” The New York Times (Saturday, October 1, 2022): A14.

(Note: the online version of the commentary was updated Sept. 30, 2022, and has the title “New Infectious Threats Are Coming. The U.S. Probably Won’t Contain Them.”)

Regulators Slowed Development of Moderna Vaccine

How much credit for the Covid vaccines goes to government and how much to entrepreneurs? Loftus’s book focuses on Moderna, and makes the case that government deserves considerable credit, mostly for early funding. A case can be made that at least as much focus should be given to BioNTech. If BioNTech had been the focus, that case might have been harder to make.

(p. C5) In late 2019, just weeks before the world heard of Covid-19, scientists from the National Institute of Allergy and Infectious Diseases visited the new manufacturing plant of a small, 9-year-old biotechnology company called Moderna. The company’s leaders boasted that the new plant in Norwood, Mass., could make a batch of a newly designed vaccine in 60 days—rapid by standard timelines that usually take 12 months or more.

. . .

One Friday afternoon in August [2020], the company was expecting delivery of large air-handling units to help expand production at its factory. Moderna had hired construction cranes to lift the tractor-trailer-sized units onto the roof of its plant. But delivery was delayed because the supplier lacked all the state permits needed to transport oversize cargo from the Midwest to Massachusetts. If the units didn’t get there by Sunday, Moderna would lose the cranes and a week of production.

Frantic, Moderna executives called Warp Speed officials. They gave the job to an Army colonel, who leaned on state officials, who in turn sent state police with sirens blaring to escort the delivery to their state line and then hand off the convoy to a new escort. The precious cargo rolled into Moderna’s plant on Sunday morning, in time for the cranes.

The much larger and older Pfizer, meanwhile, mostly opted out of Operation Warp Speed for fear it would slow the company down. As for Moderna’s collaboration, it generated enough friction to make the company’s chief medical officer during 2020, Tal Zaks, question at times whether it was worth it to accept the federal assistance.

Dr. Zaks had wanted to use a private contract research organization to run the whole trial, but NIAID officials wanted their clinical-trial network involved. Eventually, Dr. Zaks backed off, and both entities participated. “I realized we were at an impasse, and I was the embodiment of the impasse,” Dr. Zaks said.

Next, when Moderna’s 30,000-person study began enrolling volunteers in July 2020, the subjects weren’t racially diverse enough. Moncef Slaoui, who led Warp Speed’s vaccine efforts, and Dr. Fauci began holding Saturday Zoom calls with Mr. Bancel and other Moderna leaders to “help coax and advise Moderna how to get the percentage of minorities up to a reasonable level,” Dr. Fauci recalled.

Drs. Fauci and Slaoui wanted Moderna to slow down overall enrollment, to give time to find more people of color. Moderna executives resisted at first. “That was very tense,” Dr. Slaoui said. “Voices went up, and emotions were very high.” Moderna ultimately agreed, and the effort worked, but it cost the trial about an extra three weeks. Later, Mr. Bancel called the decision to slow enrollment “one of the hardest decisions I made this year.”

For the full essay, see:

Peter Loftus. “The Partnership That Made the First U.S. Covid Vaccine.” The Wall Street Journal (Saturday, July 30, 2022): C5.

(Note: ellipsis, and bracketed year, added.)

(Note: the online version of the essay has the date July 29, 2022, and has the same title as the print version.)

The essay quoted above is an adaptation from Loftus’s book:

Loftus, Peter. The Messenger: Moderna, the Vaccine, and the Business Gamble That Changed the World. Boston: Harvard Business Review Press, 2022.

American Economic Association Mandating KN-95 Mask-Wearing at January 2023 Conference

(p. A15) I was looking forward to the American Economic Association’s January [2023] conference in New Orleans after two years of virtual meetings. Then I got this notice from the AEA: “All registrants will be required to be vaccinated against COVID-19 and to have received at least one booster. High-quality masks (i.e., KN-95 or better) will be required in all indoor conference spaces. These requirements are planned for the well-being of all participants.”

Seriously? This isn’t 2020—it’s 2023. Everyone else has been getting back to normal, and being exposed to viruses is part of life.

. . .

China still has mandates in place. Maybe the AEA should hold its annual meeting in Beijing. Perhaps organizers will feel more comfortable among central planners.

. . .

I share the sentiments of George Mason University’s Tyler Cowen who said on his blog: “How about allowing a members’ vote on this? Or should I just be happy that the AEA is making itself irrelevant at such a rapid pace? It is remarkable the speed at which the economics profession isn’t really about economics anymore.”

For the full commentary, see:

Mark Skousen. “Who Was That Masked Economist?” The Wall Street Journal (Thursday, Sept. 8, 2022): A15.

(Note: ellipses added.)

(Note: the online version of the commentary has the date September 7, 2022, and has the same title as the print version.)

Weary and Angry with Lockdowns in China, “Everyone Is Scared”

(p. A12) In the hours before the southern Chinese city of Chengdu entered a coronavirus lockdown, Matthew Chen visited four vegetable markets in an attempt to stock up on fresh food. But seemingly the entire city had the same idea, and by the time he got to each place, most of the shelves had been stripped bare, except for hot peppers and fruit, he said.

Mr. Chen, a white-collar worker in his 30s, managed to scavenge enough cherry tomatoes, meat and greens for about one day, and since then has been ordering grocery deliveries to tide him through the lockdown, which began on Friday. But he worries about whether that supply will remain stable, and how much longer he will have to rely on it.

“The longer a lockdown goes, the more problems emerge, and the harder it is to tolerate it,” he said, noting that the Chengdu government had not given a timeline for reopening.

. . .

The challenges in enforcing such extensive controls are daunting, perhaps more so now than at any other point in the pandemic. Nearly three years of on-and-off lockdowns have lashed the economy, sending unemployment soaring, especially among young people. The country is increasingly isolated, as the rest of the world largely abandons Covid restrictions. New subvariants are ever more transmissible. And the seemingly endless restrictions leave more ordinary Chinese people wearier by the day.

. . .

Chengdu officials themselves have already tested residents’ trust, after the authorities last week ordered a man detained for 15 days, accusing him of spreading false rumors on social media about a looming lockdown. Two days later, when the city did actually lock down, social media erupted with support for the man and anger at the government.

“Everyone is scared, scared that the situation will become like Shanghai,” said Mr. Chen, the office worker, who had traveled to Chengdu on business before becoming trapped there by the restrictions.

Still, he saw little alternative but to bear with the situation. “Personally, I’m extremely fed up with and not supportive of these policies. But there’s nothing I can do,” he said. “I can only wait.”

For the full story, see:

Vivian Wang. “As Beijing Imposes More Covid Lockdowns Across China, ‘Everyone Is Scared’.” The New York Times (Tuesday, September 6, 2022): A12.

(Note: ellipses added.)

(Note: the online version has the date Sept. 5, 2022, and has the title “As China Imposes More Covid Lockdowns, ‘Everyone Is Scared’.”)

Covid-19 Health Effects Will Keep Reducing Labor Force

(p. A1) As the United States emerges from the pandemic, employers have been desperate to hire. But while demand for goods and services has rebounded, the supply of labor has fallen short, holding back the economy.

. . .

(p. A20) Morning Consult found in August [2022] that prime-age adults who aren’t working cited a variety of often overlapping reasons for not wanting jobs. In a monthly poll of 2,200 people, 40 percent said they believed that they wouldn’t be able to find a job with enough flexibility, while 38 percent were limited by family situations and personal obligations. But the biggest category, at 43 percent, was medical conditions.

Other data suggest some of that is due to long-term complications from Covid-19, although estimates of how many people have been knocked out of the work force by Covid range tremendously.

Katie Bach, a Brookings Institution fellow, put the impact at two million to four million full-time workers, based on her interpretation of the Census Bureau’s Household Pulse Survey and other research. (The total affected may be larger, with many who suffer from long Covid reducing their hours rather than stopping work.) A Federal Reserve economist didn’t specify a number, but observed that even as Covid-related hospitalizations and deaths receded, the share of people saying they were not able to work because of illness or disability had remained elevated in Labor Department data after spiking in early 2021.

Another analysis, in a paper published by the National Bureau of Economic Research, found that people who’d taken a week off for health-related reasons in 2020 and 2021 were 7 percent less likely to be in the labor force a year later — which equates to about 500,000 workers.

Whatever the magnitude, the effects are likely to be significant and long-lasting. Vaccines provide imperfect protection against getting long Covid, studies suggest, and other post-viral diseases have proven difficult to recover from. “I certainly don’t think the worst is behind us,” Ms. Bach said.

For the full story, see:

Lydia DePillis. “Pool of Labor In U.S. Stays Bafflingly Low.” The New York Times (Saturday, September 13, 2022): A1 & A20.

(Note: ellipsis, and bracketed year, added.)

(Note: the online version has the date Sept. 12, 2022, and has the title “Who Are America’s Missing Workers?”)

The NBER paper mentioned above is:

Goda, Gopi Shah, and Evan J. Soltas. “The Impacts of Covid-19 Illnesses on Workers.” National Bureau of Economic Research Working Paper No. 30435, Sept. 2022.

Costs of Covid Lockdowns and Mask Mandates Exceeded Benefits

(p. A15) The Centers for Disease Control and Prevention belatedly admitted failure this week. “For 75 years, CDC and public health have been preparing for Covid-19, and in our big moment, our performance did not reliably meet expectations,” Director Rochelle Walensky said. She vowed to establish an “action-oriented culture.”

. . .

U.S. states with more-restrictive policies fared no better, on average, than states with less-restrictive policies. There’s still no convincing evidence that masks provided any significant benefits. When case rates throughout the pandemic are plotted on a graph, the trajectory in states with mask mandates is virtually identical to the trajectory in states without mandates. (The states without mandates actually had slightly fewer Covid deaths per capita.) International comparisons yield similar results. A Johns Hopkins University meta-analysis of studies around the world concluded that lockdown and mask restrictions have had “little to no effect on COVID-19 mortality.”

. . .

In 2006 he and colleagues at the University of Pittsburgh considered an array of proposed measures to deal with a virus as deadly as the 1918 Spanish flu.

Should schools be closed? Should everyone wear face masks in public places? Should those exposed to an infection be required to quarantine at home? Should public-health officials rely on computer models of viral spread to impose strict limitations on people’s movements? In each case, the answer was no, because there was no evidence these measures would make a significant difference.

“Experience has shown,” Henderson’s team concluded, “that communities faced with epidemics or other adverse events respond best and with the least anxiety when the normal social functioning of the community is least disrupted.” The researchers specifically advised leaders not to be guided by computer models, because no model could reliably predict the effects of the measures or take into account the “devastating” collateral damage. If leaders overreacted and panicked the public, “a manageable epidemic could move toward catastrophe.”

This advice was subsequently heeded in the pre-Covid pandemic plans prepared by the CDC and other public-health agencies. The WHO’s review of the scientific literature concluded that there was “no evidence” that universal masking “is effective in reducing transmission.” The CDC’s pre-2020 planning scenarios didn’t recommend universal masking or extended school and business closures even during a pandemic as severe as the 1918 Spanish flu.

For the full commentary see:

John Tierney. “Fauci and Walensky Double Down on Failure.” The Wall Street Journal (Friday, Aug. 19, 2022): A15.

(Note: ellipses added.)

(Note: the online version of the commentary has the date August 18, 2022, and has the title “Fauci and Walensky Double Down on Failed Covid Response.”)

Human Challenge Trial Sped Phase 3 of Typhoid Vaccine Clinical Trial

Observers Give Thumbs-Up to Matthew Speight as He Prepared to Drink Typhoid Bacteria as Part of a Human Challenge Trial.
Source of Image: NYT commentary cited below.

(p. D3) “I was curious.” That’s how James M. Duggan, an Oxford University medical student, explains why he agreed to swallow a big dose of live typhoid bacteria.

. . .

Mr. Duggan, 33, was not on a self-destructive sympathy bender. Like more than 100 other residents of Oxford, England, he was taking part in a trial of a new typhoid vaccine.

Typhoid fever, caused by the bacteria Salmonella typhi and spread in food and water, kills almost 200,000 victims a year — many of them young children — in Africa, Asia and Latin America. Survivors may suffer perforated intestines, heart problems and other complications.

The experimental vaccine was a big success. The trial’s results were published in The Lancet on Thursday [Sept. 28, 2017]: the vaccine turned out to be 87 percent effective.

. . .

“These are great results,” said Dr. Anita Zaidi, the foundation’s director of diarrheal diseases. “And challenge tests are a great way to short-circuit the process of proving it works.

“If we’d done this in the field, we would have had to follow children for three or four years.”

So-called challenge tests involve giving subjects an experimental vaccine and then deliberately infecting them with the disease to see if it protects them.

These tests can only be done with illnesses — like cholera or malaria — that can be rapidly and completely cured, or with diseases — like seasonal flu — that normally do not damage healthy adults.

. . .

So what would motivate dozens of well-educated Britons to swallow a vial full of the germs that made Typhoid Mary famous? In interviews, they gave various reasons.

Some, like Mr. Duggan, were curious. Some wanted to help poor people. And some mostly wanted the cash.

Participants who followed all the steps, which included recording their temperatures online, making daily clinic visits and providing regular blood and stool samples, received about $4,000.

They all said they understood the risks.

For the full commentary see:

Donald G. McNeil Jr. “Curiosity, and Cash, Fight a Fever.” The New York Times (Tuesday, October 3, 2017): D3.

(Note: ellipses, and bracketed date, added.)

(Note: the online version of the commentary has the date Sept. 28, 2017, and has the title “They Swallowed Live Typhoid Bacteria — On Purpose.”)

The print version of The Lancet article mentioned above is:

Jin, Celina, Malick M. Gibani, Maria Moore, Helene B. Juel, Elizabeth Jones, James Meiring, Victoria Harris, Jonathan Gardner, Anna Nebykova, Simon A. Kerridge, Jennifer Hill, Helena Thomaides-Brears, Christoph J. Blohmke, Ly-Mee Yu, Brian Angus, and Andrew J. Pollard. “Efficacy and Immunogenicity of a Vi-Tetanus Toxoid Conjugate Vaccine in the Prevention of Typhoid Fever Using a Controlled Human Infection Model of Salmonella Typhi: A Randomised Controlled, Phase 2b Trial.” The Lancet 390, no. 10111 (Dec. 2, 2017): 2472-80.

Leftist Anti-Covid-Vaccine Roman Catholic Nun Defends Free Speech

(p. A12) MONTSERRAT, Spain — Sister Teresa Forcades came to public notice years ago for her unflinching liberal views: an outspoken Roman Catholic nun whose pronouncements ran counter to the church’s positions on same-sex marriage and abortion.

She became a fixture on Spanish television, appearing in her nun’s habit to advocate independence for her native region of Catalonia, and to debate other hot-button topics, including vaccines. She had trained as a doctor, partly in the United States, and argued that vaccinations might one day pose a danger to a free society.

. . .

“It’s always important that criticism is possible, to have dissenting voices,” she said of her views, which center as much on her doubts about the vaccines as her right to question them in public. “The answer cannot be that in the time of a crisis, society cannot allow the criticism — it’s precisely then that we need it.”

. . .

In the world of vaccine skeptics, Sister Teresa, who was born in 1966 to a nurse and a commercial agent, is hard to categorize. She acknowledges that some vaccines are beneficial, but opposes making them mandatory. Her misgivings about coronavirus vaccines largely stem from her view that pharmaceutical companies are not to be trusted, and the clinical trials were rushed.

. . .

Sister Teresa, though staunchly leftist, doesn’t distance herself from right-wing followers, calling her distrust of some vaccines a “transversal question able to reach a wide spectrum of people.”

For the full story see:

Nicholas Casey. “Spanish Nun With Medical Training Champions Vaccine Distrust.” The New York Times (Saturday, April 24, 2021): A12.

(Note: ellipses added.)

(Note: the online version of the article has the date April 23, 2021, and has the title “A Nun and a Doctor, She’s One of Europe’s Longstanding Vaccine Skeptics.”

Those Who Survived Dictatorship Know We Need “More Freedom, More Speech, Not Less”

(p. A19) The left’s reaction to Mr. Trump’s rhetoric was instructive. Anyone who mentioned the lab-leak theory was assailed as pro-Trump. Social-media companies removed posts mentioning it. By January 2021, it was obvious that shutting down debate was the true antiscience position. Invaluable months were lost, time the Chinese Communist Party used to destroy data and spread disinformation about the virus’s origins. We may never know the truth, but we do know there was a coverup.

Increasing numbers of Americans believe their freedom is under attack, and I agree. . . .

Schools are being pressured to remove books and cancel professors for spreading the “wrong” ideas. These sentiments are all too familiar to me, and to anyone who has survived life in a dictatorship. The only answer is more freedom, more speech, not less.

For the full commentary see:

Garry Kasparov. “‘Woke’ Is a Bad Word for a Real Threat to American Democracy.” The Wall Street Journal (Thursday, Nov. 18, 2021): A19.

(Note: ellipsis added.)

(Note: the online version of the commentary has the date November 17, 2021, and has the same title as the print version.

“Paradox”: “Masks Work and Mask Mandates Do Not Work”

(p. A19) The Evidence

From the beginning of the pandemic, there has been a paradox involving masks. As Dr. Shira Doron, an epidemiologist at Tufts Medical Center, puts it, “It is simultaneously true that masks work and mask mandates do not work.”

To start with the first half of the paradox: Masks reduce the spread of the Covid virus by preventing virus particles from traveling from one person’s nose or mouth into the air and infecting another person. Laboratory studies have repeatedly demonstrated the effect.

Given this, you would think that communities where mask-wearing has been more common would have had many fewer Covid infections. But that hasn’t been the case.

In U.S. cities where mask use has been more common, Covid has spread at a similar rate as in mask-resistant cities. Mask mandates in schools also seem to have done little to reduce the spread. Hong Kong, despite almost universal mask-wearing, recently endured one of the world’s worst Covid outbreaks.

Advocates of mandates sometimes argue that they do have a big effect even if it is not evident in populationwide data, because of how many other factors are at play. But this argument seems unpersuasive.

After all, the effect of vaccines on severe illness is blazingly obvious in the geographic data: Places with higher vaccination rates have suffered many fewer Covid deaths. The patterns are clear even though the world is a messy place, with many factors other than vaccines influencing Covid death rates.

Yet when you look at the data on mask-wearing — both before vaccines were available and after, as well as both in the U.S. and abroad — you struggle to see any patterns.

Almost 30 Percent

The idea that masks work better than mask mandates seems to defy logic. It inverts a notion connected to Aristotle’s writings: that the whole should be greater than the sum of the parts, not less.

The main explanation seems to be that the exceptions often end up mattering more than the rule. The Covid virus is so contagious that it can spread during brief times when people take off their masks, even when a mandate is in place.